S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

BIOQUAL Stock Price, News & Analysis (OTCMKTS:BIOQ)

$36.25
+0.25 (+0.69 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$36.25
Now: $36.25
$36.25
50-Day Range
$30.00
MA: $33.47
$35.50
52-Week Range
$28.00
Now: $36.25
$41.00
Volume579 shs
Average Volume1,027 shs
Market Capitalization$32.41 million
P/E Ratio11.23
Dividend Yield1.94%
Beta0.09
Bioqual, Inc. provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases. Its services also include sample processing, virus stock generation, infectious virus quantitation, virus neutralization assays, hemagglutination inhibition assays, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BIOQ
CUSIP09065J101
Phone301-251-2801

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$39.48 million

Profitability

Net Income$2.83 million

Miscellaneous

EmployeesN/A
Market Cap$32.41 million
Next Earnings Date10/18/2019 (Estimated)
OptionableNot Optionable

Receive BIOQ News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOQ and its competitors with MarketBeat's FREE daily newsletter.


BIOQUAL (OTCMKTS:BIOQ) Frequently Asked Questions

What is BIOQUAL's stock symbol?

BIOQUAL trades on the OTCMKTS under the ticker symbol "BIOQ."

How often does BIOQUAL pay dividends? What is the dividend yield for BIOQUAL?

BIOQUAL declared an annual dividend on Friday, September 13th. Investors of record on Wednesday, September 25th will be paid a dividend of $0.70 per share on Wednesday, October 16th. This represents a yield of 2%. The ex-dividend date of this dividend is Tuesday, September 24th. This is an increase from BIOQUAL's previous annual dividend of $0.60. View BIOQUAL's Dividend History.

How were BIOQUAL's earnings last quarter?

BIOQUAL, Inc. (OTCMKTS:BIOQ) issued its quarterly earnings results on Friday, September, 13th. The company reported $1.30 earnings per share (EPS) for the quarter. The business earned $11.56 million during the quarter. View BIOQUAL's Earnings History.

When is BIOQUAL's next earnings date?

BIOQUAL is scheduled to release their next quarterly earnings announcement on Friday, October 18th 2019. View Earnings Estimates for BIOQUAL.

Has BIOQUAL been receiving favorable news coverage?

Press coverage about BIOQ stock has been trending negative recently, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BIOQUAL earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for BIOQUAL.

Who are some of BIOQUAL's key competitors?

Who are BIOQUAL's key executives?

BIOQUAL's management team includes the folowing people:
  • Dr. David A. Newcomer, Chief Financial Officer (Age 58)
  • Dr. Marisa St. Claire DVM, VP - Primate Biology and Medicine (Age 54)
  • Dr. Mark G. Lewis, Chairman, CEO & Pres (Age 64)
  • Mitch Franklin, Chief Operating Officer
  • Nancy A. Madden, VP of Admin. Operations & Biosafety Officer

How do I buy shares of BIOQUAL?

Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BIOQUAL's stock price today?

One share of BIOQ stock can currently be purchased for approximately $36.25.

How big of a company is BIOQUAL?

BIOQUAL has a market capitalization of $32.41 million and generates $39.48 million in revenue each year. View Additional Information About BIOQUAL.

What is BIOQUAL's official website?

The official website for BIOQUAL is http://www.bioqual.com/.

How can I contact BIOQUAL?

BIOQUAL's mailing address is 9600 MEDICAL CENTER DR, ROCKVILLE MD, 20850. The company can be reached via phone at 301-251-2801.


MarketBeat Community Rating for BIOQUAL (OTCMKTS BIOQ)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  98 (Thanks for Voting!)
Underperform Votes:  87 (Thanks for Voting!)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about BIOQUAL and other stocks. Vote "Outperform" if you believe BIOQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIOQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel